- The Law
Welcome to My Meds Matter
In Enforcing Drug Compounding Law
Compounding pharmacies, which customize drugs for individual patients, say the FDA is overstepping its authority and jeopardizing patient access to compounded medications.
Major concern about committee recommendation for Beyond-Use-Dating
New rule would cut access to compounds in California, Increase costs
H.R. 2871, The Preserving Patient Access to Compounded Medications Act of 2017
NCPA supports Congress's efforts to assure appropriate oversight of compounding pharmacies in a way that does not curtail or hinder patient access to those specially-tailored medications.
Committee Demands Radical Policy Revisions
House Appropriations Committee says FDA policies go against Congressional intent
Addresses confusion over a compounding pharmacy’s “distribution” of compounded preparations
Senator David Vitter (R-LA) introduced S. 1406, the Saving Access to Compounded Medications for Special Needs Patients Act
Proposed policy lays out new rules for veterinarians
The U.S. Food and Drug Administration has made good on a decade-old promise to provide updated guidance on the regulatory complexities of compounding animal drugs from bulk substances.
No front page content has been created yet.